These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33610078)

  • 1. Multiple arrhythmic and cardiomyopathic phenotypes associated with an SCN5A A735E mutation.
    Sasaki T; Ikeda K; Nakajima T; Kawabata-Iwakawa R; Iizuka T; Dharmawan T; Tamura S; Niwamae N; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    J Electrocardiol; 2021; 65():122-127. PubMed ID: 33610078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced closed-state inactivation of mutant cardiac sodium channels (SCN5A N1541D and R1632C) through different mechanisms.
    Dharmawan T; Nakajima T; Iizuka T; Tamura S; Matsui H; Kaneko Y; Kurabayashi M
    J Mol Cell Cardiol; 2019 May; 130():88-95. PubMed ID: 30935997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel.
    Chen J; Li H; Guo S; Yang Z; Sun S; Zeng J; Gou H; Chen Y; Wang F; Lin Y; Huang K; Yue H; Ma Y; Lin Y
    Orphanet J Rare Dis; 2022 Oct; 17(1):394. PubMed ID: 36303204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCN5A mutation status increases the risk of major arrhythmic events in Asian populations with Brugada syndrome: systematic review and meta-analysis.
    Rattanawong P; Chenbhanich J; Mekraksakit P; Vutthikraivit W; Chongsathidkiet P; Limpruttidham N; Prasitlumkum N; Chung EH
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12589. PubMed ID: 30126015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
    Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
    Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number variations of SCN5A in Brugada syndrome.
    Sonoda K; Ohno S; Ozawa J; Hayano M; Hattori T; Kobori A; Yahata M; Aburadani I; Watanabe S; Matsumoto Y; Makiyama T; Horie M
    Heart Rhythm; 2018 Aug; 15(8):1179-1188. PubMed ID: 29574140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-Phenotype Correlation of
    Milman A; Behr ER; Gray B; Johnson DC; Andorin A; Hochstadt A; Gourraud JB; Maeda S; Takahashi Y; Jm Juang J; Kim SH; Kamakura T; Aiba T; Postema PG; Mizusawa Y; Denjoy I; Giustetto C; Conte G; Huang Z; Sarquella-Brugada G; Mazzanti A; Jespersen CH; Arbelo E; Brugada R; Calo L; Corrado D; Casado-Arroyo R; Allocca G; Takagi M; Delise P; Brugada J; Tfelt-Hansen J; Priori SG; Veltmann C; Yan GX; Brugada P; Gaita F; Leenhardt A; Wilde AAM; Kusano KF; Nam GB; Hirao K; Probst V; Belhassen B
    Circ Genom Precis Med; 2021 Oct; 14(5):e003222. PubMed ID: 34461752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.
    Beckermann TM; McLeod K; Murday V; Potet F; George AL
    Heart Rhythm; 2014 Aug; 11(8):1446-53. PubMed ID: 24815523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Ishikawa T; Kimoto H; Mishima H; Yamagata K; Ogata S; Aizawa Y; Hayashi K; Morita H; Nakajima T; Nakano Y; Nagase S; Murakoshi N; Kowase S; Ohkubo K; Aiba T; Morimoto S; Ohno S; Kamakura S; Nogami A; Takagi M; Karakachoff M; Dina C; Schott JJ; Yoshiura KI; Horie M; Shimizu W; Nishimura K; Kusano K; Makita N
    Eur Heart J; 2021 Jul; 42(29):2854-2863. PubMed ID: 34219138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.
    Robyns T; Nuyens D; Vandenberk B; Kuiperi C; Corveleyn A; Breckpot J; Garweg C; Ector J; Willems R
    Ann Noninvasive Electrocardiol; 2018 Sep; 23(5):e12548. PubMed ID: 29709101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
    Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
    Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function KCNH2 mutations in patients with Brugada syndrome.
    Wang QI; Ohno S; Ding WG; Fukuyama M; Miyamoto A; Itoh H; Makiyama T; Wu J; Bai J; Hasegawa K; Shinohara T; Takahashi N; Shimizu A; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 May; 25(5):522-530. PubMed ID: 24400717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
    J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.
    Maury P; Moreau A; Hidden-Lucet F; Leenhardt A; Fressart V; Berthet M; Denjoy I; Bennamar N; Rollin A; Cardin C; Guicheney P; Chahine M
    J Interv Card Electrophysiol; 2013 Aug; 37(2):131-40. PubMed ID: 23612926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.